9.000
+0,00%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -28.4% | +25.5% | 2 / 3 | -37.4% | +2.23 pp | +0.56 pp | +8.3% | 0.22 | 8.95 | 73,2 | −37,4% | 3,3 | −28,4% | 8.95 | 9.50 | −5,8% |
| Pts | 0 | 4 | 8 | 0 | 8 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 9.000 (close price on 2026-10-19)EPS (TTM): 1.005
Financial charts
1.Revenue & growth
VND bn73,2Q2/26
1.Revenue & growth
VND bn73,2Q2/26
2.Profit & growth
VND bn3,28Q2/26
3.Profit mix (Penman)
VND bn18,8Q2/26
4.Margins & cost structure
%11.7%Q2/26
5.Returns & cash cycle
% · days9.5%Q2/26
6.Earnings quality & cash
VND bn-49,5Q2/26
7.Asset structure
VND bn264Q2/26
8.Funding & debt health
VND bn · times264Q2/26
9.Revenue backlog
VND bn6,48Q2/26
10.Valuation
times · %9,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %219Q2/26
Adjusted EPS growth, latest quarter
-28.5%
Average adjusted EPS growth, 3 quarters
25.5%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26